Pharmacy

A California jury ordered Johnson & Johnson to pay $29 million to a woman who alleged that asbestos in the company's talc-based baby powder caused her fatal cancer, according to Bloomberg.

Oral forms of medications include inactive ingredients to help stabilize the drug or aid in its absorption. While these components are usually harmless, nearly all of these pills contain some ingredients that can cause allergic reactions, a new study published…

The chief executive of Novartis' generic drug business Sandoz abruptly stepped down, according to Reuters.

CMS updated its drug spending dashboards with pricing and spending data from 2017 to help increase transparency in healthcare and provide incentives to lower list prices.

Deerfield Management, a healthcare hedge fund, has invested $100 million in a new research and development partnership with Cambridge, Mass.-based Harvard University, according to The Boston Globe.

Purdue Pharma's CEO said a bankruptcy filing is on the table as lawsuits alleging the drugmaker fueled the nation's opioid crisis pile up, according to The Washington Post.

Entry of generic drugs into the market should cause prices to drop. However, the generic industry has recently taken a page from the brand-name industry, engaging in price gouging and making it increasingly difficult to obtain critical medications, Marc Harrison,…

As costs continue to mount from opioid litigation, Insys Therapeutics faces the risk of going out of business, according to Bloomberg.

Several drugmakers and pharmacy chains are hard at work responding to the hundreds of lawsuits accusing them of fueling the deadly opioid epidemic in the U.S. While billions of dollars are at stake for these companies if they are found…

Specialty drugmaker Sonoma Pharmaceuticals will reduce its workforce in an effort to slow "cash burn."